scispace - formally typeset
V

Vikas Saxena

Researcher at University of Maryland, Baltimore

Publications -  42
Citations -  534

Vikas Saxena is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Medicine & Immune system. The author has an hindex of 10, co-authored 23 publications receiving 311 citations. Previous affiliations of Vikas Saxena include Academia Sinica & Ohio State University.

Papers
More filters
Journal ArticleDOI

Annexin A2 is involved in the formation of hepatitis C virus replication complex on the lipid raft

TL;DR: It is proposed that Anxa2 recruits HCV NS proteins and enriches them on the lipid raft to form the HCV replication complex.
Journal ArticleDOI

Affinity chromatography: A versatile technique for antibody purification.

TL;DR: A detailed overview on affinity chromatography and the components involved in purification is provided to provide a detailed overview of antibody purification methodologies and their underlying working principles.
Journal ArticleDOI

Gut microbiota–dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes

TL;DR: Analysis of mesenteric and peripheral lymph node structure showed that B. pseudolongum gavage resulted in a higher laminin α4/α5 ratio in the lymph node cortical ridge, indicative of a suppressive environment, while D. desulfuricans results in a lower lamination ratio, supportive of inflammation.
Journal ArticleDOI

NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality.

TL;DR: It is shown that in T cells transitioning to memory, the expression of high levels of Eomes is not constitutive but rather requires a continuum of cell-intrinsic NFκB signaling, which regulates Eomes levels to maintain memory fitness.
Journal ArticleDOI

Role of lymph node stroma and microenvironment in T cell tolerance

TL;DR: Increased understanding of LN architecture, how different LN SCs integrate immunological cues and shape immune responses, and approaches to induce T cell tolerance will help further combat autoimmune diseases and graft rejection.